Evidence map›Paper›PMID 41760656›Full record

ArticleNature communications2026

Rank signaling drives basal cell-lineage infidelity leading to mammary tumorigenesis.

Jaime Redondo-Pedraza, Patricia G Santamaría, Alejandro Sanchez-Juan, María Jimenez, Ana Sofia Rocha, Gonzalo Soria-Alcaide, José Terrón-Bautista, Ruth Álvarez, Víctor López, Osvaldo Graña-Castro and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jaime Redondo-PedrazaTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-9520-1619
Patricia G Santamaría *Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Alejandro Sanchez-Juan *Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0009-0001-8902-9074
María Jimenez *Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0003-2673-6369
Ana Sofia RochaOncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7229-5379
Gonzalo Soria-AlcaideTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0001-5141-2177
José Terrón-BautistaTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-8621-8021
Ruth ÁlvarezBioinformatics Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0003-0141-4881
Víctor LópezTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Osvaldo Graña-CastroBioinformatics Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Eduardo CaleirasHistopathology Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Pilar Ximénez-EmbúnProteomics Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-2582-9443
Helga BergholtzDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0003-0999-1106
Heena DalalDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.ORCID http://orcid.org/0000-0003-1868-1388
G Kenneth GrayDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0003-4969-670X
Marta IsasaProteomics Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0009-0005-6865-9500
Therese SørlieDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-5995-2319
Walid T KhaledDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.ORCID http://orcid.org/0000-0001-9068-5776
Felipe Cortés-LedesmaTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-0440-6783
Christopher G MuellerCNRS UPR 3572, Immunologie, Immunopathologie et Chimie Thérapeutique, Université de Strasbourg, Strasbourg, France.ORCID http://orcid.org/0000-0002-4119-2729
Eva González-SuárezTumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain. egonzalez@cnio.es.ORCID http://orcid.org/0000-0003-0858-8171

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rank signaling regulates mammary gland development and epithelial differentiation. While Rank is expressed in both basal and luminal cells, its basal-specific role is unclear. Here, using inducible basal-specific Rank expression and lineage tracing, we show that Rank signaling regulates basal cell identity in postnatal mammary glands. Increased basal Rank activity disrupts basal and luminal identities, causing aberrant luminal-like differentiation, lactation defects, and premalignant lesions composed of hybrid basal-derived cells that progress to basal and luminal adenocarcinomas. Conversely, Rank loss reduces tumor formation and also impairs cell identity. Mechanistically, proteomic, transcriptomic, and chromatin analyses reveal that Rank activation drives epigenetic remodeling, leading to basal identity loss and tumor initiation. A basal Rank gene signature correlates with ductal carcinoma in situ recurrence, as well as poor outcomes in luminal breast cancers. Thus, basal Rank-driven lineage infidelity promotes pre-invasive lesions and transition to invasive breast cancer in females.

Indexed as

Breast NeoplasmsCarcinogenesisCell LineageAnimalsCell DifferentiationFemaleGene Expression Regulation, NeoplasticHumansMammary Glands, AnimalMiceSignal Transduction

Identifiers

PMID41760656
PMCPMC13153180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.